GGrantIndex
← Leaderboards

Monica Guma

University Of California, San Diego

$5,338,014
Attributed
$5,854,755
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY201325
$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,854,755 · 6

By mechanism

R01$3,303,906 · 2
T32$1,253,685 · 1
K08$687,075 · 1
R21$377,589 · 1
R03$232,500 · 1

Top collaborators

Most similar at University Of California, San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Pathogenesis

Research focus

PathogenesisArthritisPhenotypeSamplingJoint DestructionCartilageCellsInflammationPathway InteractionsRheumatoid ArthritisJointsTissuesFibroblastsInflammatoryMigrationKnock-DownEnzymesSynovial MembranePharmaceutical PreparationsMetabolismMetabolicSynovitisAffectBone

Grant awards (27)

Obesity-Induced Inflammatory Mediators Predict Lack of Response in Patients with Rheumatoid Arthritis Starting Biological Therapies$440,563
R01 · FY2025 · AR · contact PI
Rheumatic Diseases Research Training Grant$279,925
T32 · FY2025 · AR · contact PI
Obesity-Induced Inflammatory Mediators Predict Lack of Response in Patients with Rheumatoid Arthritis Starting Biological Therapies$506,085
R01 · FY2024 · AR · contact PI
Rheumatic Diseases Research Training Grant$375,968
T32 · FY2024 · AR · contact PI
Can circulating bile acids predict knee OA progression?$168,839
R21 · FY2024 · AR · contact PI
Rheumatic Diseases Research Training Grant$313,360
T32 · FY2023 · AR · contact PI
Can circulating bile acids predict knee OA progression?$208,750
R21 · FY2023 · AR · contact PI
Targeting hexokinase-2 in rheumatoid arthritis$344,124
R01 · FY2022 · AR · contact PI
Rheumatic Diseases Research Training Grant$284,432
T32 · FY2022 · AR · contact PI
Targeting hexokinase-2 in rheumatoid arthritis$277,059
R01 · FY2022 · AR · contact PI
Targeting hexokinase-2 in rheumatoid arthritis$120,044
R01 · FY2022 · AR · contact PI
Targeting hexokinase-2 in rheumatoid arthritis$337,120
R01 · FY2021 · AR · contact PI
Targeting hexokinase-2 in rheumatoid arthritis$92,403
R01 · FY2021 · AR · contact PI
Targeting hexokinase-2 in rheumatoid arthritis$346,448
R01 · FY2020 · AR · contact PI
Targeting hexokinase-2 in rheumatoid arthritis$65,800
R01 · FY2020 · AR · contact PI
Targeting hexokinase-2 in rheumatoid arthritis$345,400
R01 · FY2019 · AR · contact PI
Targeting hexokinase-2 in rheumatoid arthritis$83,460
R01 · FY2019 · AR · contact PI
Targeting hexokinase-2 in rheumatoid arthritis$345,400
R01 · FY2018 · AR · contact PI
Choline metabolites as biomarkers in rheumatoid arthritis$77,500
R03 · FY2018 · AR · contact PI
Choline kinase: a novel target for rheumatoid arthritis$143,695
K08 · FY2017 · AR · contact PI
Choline kinase: a novel target for rheumatoid arthritis$143,695
K08 · FY2016 · AR · contact PI
Choline metabolites as biomarkers in rheumatoid arthritis$77,500
R03 · FY2016 · AR · contact PI
Choline kinase: a novel target for rheumatoid arthritis$1,000
K08 · FY2016 · AR · contact PI
Choline kinase: a novel target for rheumatoid arthritis$132,895
K08 · FY2015 · AR · contact PI
Choline metabolites as biomarkers in rheumatoid arthritis$77,500
R03 · FY2015 · AR · contact PI
Choline kinase: a novel target for rheumatoid arthritis$132,895
K08 · FY2014 · AR · contact PI
Choline kinase: a novel target for rheumatoid arthritis$132,895
K08 · FY2013 · AR · contact PI